Invictus Private Wealth, LLC Dexcom Inc Transaction History

Invictus Private Wealth, LLC

  • $1.26 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024
SELL
$110.31 - $140.45 $19,524 - $24,859
-177 Reduced 5.26%
3,186 $361 Million
Q1 2024

May 13, 2024
SELL
$114.22 - $140.1 $15,648 - $19,193
-137 Reduced 3.91%
3,363 $466 Million
Q4 2023

Feb 12, 2024
SELL
$75.49 - $124.16 $11,172 - $18,375
-148 Reduced 4.06%
3,500 $434 Million
Q3 2023

Oct 04, 2023
SELL
$86.06 - $137.93 $172 - $275
-2 Reduced 0.05%
3,648 $340 Million
Q4 2022

Jun 05, 2023
BUY
$84.98 - $122.67 $310,177 - $447,745
3,650 New
3,650 $413 Million

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Invictus Private Wealth, LLC Portfolio

Follow Invictus Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invictus Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invictus Private Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email